<DOC>
	<DOCNO>NCT00001155</DOCNO>
	<brief_summary>The purpose protocol continue treat patient Wegener 's granulomatosis already enter study , treat new patient . The investigator attempt correlate clinical response specific immunosuppressive effect drug administration . The investigator accumulate data optimal duration side effect therapy .</brief_summary>
	<brief_title>Treatment Wegener 's Granulomatosis With Cyclophosphamide</brief_title>
	<detailed_description>The purpose protocol continue treat patient Wegener 's granulomatosis already enter study , treat new patient . The investigator attempt correlate clinical response specific immunosuppressive effect drug administration . The investigator accumulate data optimal duration side effect therapy . Age Range : great 1 year</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Patients great 1 year age clinical pathological diagnosis WG whose illness present risk permanent disability death . Examples process impart risk permanent disability death include : peripheral central nervous system disease , cardiac involvement , glomerulonephritis , vascular comprise gastrointestinal organ . No woman pregnant intend become pregnant . No patient know malignancy . Patients must HIV negative .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2002</verification_date>
	<keyword>Vasculitis</keyword>
	<keyword>Prednisone</keyword>
	<keyword>Granuloma</keyword>
	<keyword>Wegener 's Granulomatosis</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Renal Biopsy</keyword>
</DOC>